IPHA News
August 20, 2024
The shared ambition of IPHA member companies is to make available life-enhancing medicines including vaccines, for patients in Ireland via those entitled to prescribe and supply. In […]
August 7, 2024
On June 28th, IPHA published the Transfer of value (ToV) Disclosure data for 2023. The total ToV amount for 2023 was €29,039,301 which is a 10% […]
July 30, 2024
IPHA members expect to make applications for reimbursement for 36 medicines in 2025, benefitting as many as 3,700 patients in Ireland. The funding of new medicines […]
July 22, 2024
The IPHA Annual Conference and dinner will take place at the Dublin Royal Convention Centre on Wednesday 26th February, 2025. Further details will be announced later. […]
May 19, 2024
The HSE and the Irish Pharmaceutical Healthcare Association (IPHA) wishes to improve Ireland’s clinical trial footprint and today they announce a significant development to achieve that […]
May 18, 2024
Irish Pharmaceutical Healthcare Association launches EU manifesto in each of the Ireland constituencies ahead of upcoming European Parliament Elections.
May 12, 2024
Denmark attracts almost three times as many industry clinical trials when compared to Ireland. IPHA calls for reform of the system to ensure patients in Ireland […]
